P.4.046 Donepezil-treated Alzheimer's disease patients with apparent initial cognitive decline demonstrate significant benefits when therapy is continued: Results from a randomized, placebo-controlled trial

✍ Scribed by W. Kozubski; S. Hasselbalch; G. Jakab; C.J. Kalisvaart; A. Kurz; J. McCarthy; E. Triau; M. Tsolaki; L. Bergendorff; Y. Xu; N. Kumar; S. Richardson; P. Johannsen

• Book ID: 119577274
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 143 KB
• Volume: 13
• Category: Article
• ISSN: 0924-977X
• DOI: 10.1016/s0924-977x(03)92240-1